Which patients benefit from adding short-term psychodynamic psychotherapy to antidepressants in the treatment of depression? A systematic review and meta-analysis of individual participant data.


Journal

Psychological medicine
ISSN: 1469-8978
Titre abrégé: Psychol Med
Pays: England
ID NLM: 1254142

Informations de publication

Date de publication:
10 2023
Historique:
medline: 26 9 2023
pubmed: 22 11 2022
entrez: 21 11 2022
Statut: ppublish

Résumé

Adding short-term psychodynamic psychotherapy (STPP) to antidepressants increases treatment efficacy, but it is unclear which patients benefit specifically. This study examined efficacy moderators of combined treatment (STPP + antidepressants) For this systematic review and meta-analysis (PROSPERO registration number: CRD42017056029), we searched PubMed, PsycINFO, Embase.com, and the Cochrane Library from inception to 1 January 2022. We included randomized clinical trials comparing combined treatment (antidepressants + individual outpatient STPP) Data were obtained for all seven trials identified (100%, To our knowledge, this is the first study that examines moderators across trials assessing the addition of STPP to antidepressants. These findings need validation but suggest that depression severity and episode duration are factors to consider when adding STPP to antidepressants and might contribute to personalizing treatment selection for depression.

Sections du résumé

BACKGROUND
Adding short-term psychodynamic psychotherapy (STPP) to antidepressants increases treatment efficacy, but it is unclear which patients benefit specifically. This study examined efficacy moderators of combined treatment (STPP + antidepressants)
METHODS
For this systematic review and meta-analysis (PROSPERO registration number: CRD42017056029), we searched PubMed, PsycINFO, Embase.com, and the Cochrane Library from inception to 1 January 2022. We included randomized clinical trials comparing combined treatment (antidepressants + individual outpatient STPP)
RESULTS
Data were obtained for all seven trials identified (100%,
CONCLUSIONS
To our knowledge, this is the first study that examines moderators across trials assessing the addition of STPP to antidepressants. These findings need validation but suggest that depression severity and episode duration are factors to consider when adding STPP to antidepressants and might contribute to personalizing treatment selection for depression.

Identifiants

pubmed: 36404677
doi: 10.1017/S0033291722003270
pii: S0033291722003270
pmc: PMC10520584
doi:

Substances chimiques

Antidepressive Agents 0

Types de publication

Meta-Analysis Systematic Review Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

6090-6101

Références

Psychother Psychosom. 2010;79(5):295-302
pubmed: 20616624
BMJ Open. 2018 Feb 20;8(2):e018900
pubmed: 29463590
Clin Psychol Rev. 2020 Aug;80:101886
pubmed: 32650213
J R Stat Soc Ser A Stat Soc. 2009 Jan;172(1):137-159
pubmed: 19381330
BMJ. 2011 Oct 18;343:d5928
pubmed: 22008217
J Affect Disord. 2017 May;214:15-25
pubmed: 28266318
World Psychiatry. 2015 Oct;14(3):312-21
pubmed: 26407787
J Consult Clin Psychol. 2010 Oct;78(5):668-80
pubmed: 20873902
Psychol Med. 2016 Mar;46(4):731-44
pubmed: 26750445
Contemp Clin Trials Commun. 2018 Mar 28;10:80-85
pubmed: 29696162
J Am Psychoanal Assoc. 1994;42(2):421-46
pubmed: 8040550
J Affect Disord. 2001 May;64(2-3):217-29
pubmed: 11313088
Clin Psychol Rev. 2015 Dec;42:1-15
pubmed: 26281018
Psychother Psychosom. 2007;76(5):298-305
pubmed: 17700050
Psychiatr Serv. 2002 May;53(5):585-90
pubmed: 11986508
J Clin Epidemiol. 2002 Jan;55(1):86-94
pubmed: 11781126
Behav Res Methods. 2018 Oct;50(5):2016-2034
pubmed: 29071652
World Psychiatry. 2021 Jun;20(2):283-293
pubmed: 34002502
JAMA. 2015 Apr 28;313(16):1657-65
pubmed: 25919529
World Psychiatry. 2015 Jun;14(2):137-50
pubmed: 26043322
Psychiatr Serv. 2009 Jul;60(7):936-42
pubmed: 19564224
Psychother Psychosom. 2018;87(3):140-153
pubmed: 29847831
BMJ. 2011 Jul 22;343:d4002
pubmed: 21784880

Auteurs

Ellen Driessen (E)

Department of Clinical Psychology, Behavioural Science Institute, Radboud University, Nijmegen, Netherlands.
Depression Expertise Centre, Pro Persona Mental Health Care, Nijmegen, Netherlands.
Department of Clinical, Neuro and Developmental Psychology, Amsterdam Public Health Research Institute, Vrije Universiteit Amsterdam, Amsterdam, Netherlands.

Marjolein Fokkema (M)

Department of Methodology and Statistics, Leiden University, Leiden, Netherlands.

Jack J M Dekker (JJM)

Department of Research, Arkin Mental Health Care, Amsterdam, Netherlands.

Jaap Peen (J)

Department of Research, Arkin Mental Health Care, Amsterdam, Netherlands.

Henricus L Van (HL)

NPI, Arkin Mental Health Care, Amsterdam, Netherlands.

Giuseppe Maina (G)

Department of Neuroscience 'Rita Levi Montalcini', University of Turin, Turin, Italy.
Psychiatric Unit, San Luigi Gonzaga University Hospital of Orbassano, Turin, Italy.

Gianluca Rosso (G)

Department of Neuroscience 'Rita Levi Montalcini', University of Turin, Turin, Italy.
Psychiatric Unit, San Luigi Gonzaga University Hospital of Orbassano, Turin, Italy.

Sylvia Rigardetto (S)

Psychiatric Unit, San Luigi Gonzaga University Hospital of Orbassano, Turin, Italy.

Francesco Cuniberti (F)

Department of Neuroscience 'Rita Levi Montalcini', University of Turin, Turin, Italy.

Veronica G Vitriol (VG)

Medical School, University of Talca, Talca, Chile.

Antonio Andreoli (A)

Geneva University Hospital Center, Geneva, Switzerland.

Yvonne Burnand (Y)

Geneva University Hospital Center, Geneva, Switzerland.

Jaime López Rodríguez (J)

National Institute of Psychiatry, Mexico City, Mexico.

Valerio Villamil Salcedo (V)

National Institute of Psychiatry, Mexico City, Mexico.

Jos W R Twisk (JWR)

Department of Epidemiology and Data Science, Amsterdam University Medical Centers, Amsterdam, Netherlands.

Frederik J Wienicke (FJ)

Department of Clinical Psychology, Behavioural Science Institute, Radboud University, Nijmegen, Netherlands.

Pim Cuijpers (P)

Department of Clinical, Neuro and Developmental Psychology, Amsterdam Public Health Research Institute, Vrije Universiteit Amsterdam, Amsterdam, Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH